Skip to main content

WATSON 3613 Pill: beige, oval

The pill with imprint WATSON 3613 (Beige, Oval, 0mm) has been identified as Ropinirole Hydrochloride Extended-Release 4 mg and is used for Restless Legs Syndrome, Periodic Limb Movement Disorder, and Parkinson's Disease. It belongs to the drug class dopaminergic antiparkinsonism agents and is not a controlled substance.

Images for WATSON 3613

Ropinirole hydrochloride extended-release 4 mg WATSON 3613
Ropinirole hydrochloride extended-release 4 mg WATSON 3613
Ropinirole hydrochloride extended-release 4 mg WATSON 3613
Ropinirole hydrochloride extended-release 4 mg WATSON 3613

Ropinirole Hydrochloride Extended-Release

Imprint
WATSON 3613
Strength
4 mg
Color
Beige
Shape
Oval
Availability
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
National Drug Code (NDC)
00591-3613 (Discontinued)
Inactive Ingredients
hypromelloses, mannitol, glyceryl dibehenate, lactose monohydrate, hydrogenated castor oil, povidone, sodium lauryl sulfate, magnesium silicate, magnesium stearate, silicon dioxide, triethyl citrate, titanium dioxide, polydextrose, triacetin, polyethylene glycol 8000, FD&C Yellow No. 6, FD&C Blue No. 2, aluminum oxide, vinyl acetate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.